Improvement of Ankle-Brachial Index by DLBS1033 Treatment in Diabetic Patients With Peripheral Arterial Disease
Phase of Trial: Phase II/III
Latest Information Update: 03 Jul 2017
At a glance
- Drugs Lumbricus rubellus (Primary)
- Indications Peripheral arterial disorders
- Focus Therapeutic Use
- Sponsors Dexa Medica
- 28 Jun 2017 Planned End Date changed from 1 Dec 2017 to 1 Sep 2018.
- 28 Jun 2017 Planned primary completion date changed from 1 Oct 2017 to 1 Jun 2018.
- 10 Jun 2017 Biomarkers information updated